ABVC BioPharma Inc (ABVC)
0.5306
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 12:17
ABVC BioPharma Enterprise Value: 7.784M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 7.784M |
| November 12, 2024 | 7.598M |
| November 11, 2024 | 7.674M |
| November 08, 2024 | 7.679M |
| November 07, 2024 | 7.876M |
| November 06, 2024 | 8.008M |
| November 05, 2024 | 8.220M |
| November 04, 2024 | 8.981M |
| November 01, 2024 | 9.337M |
| October 31, 2024 | 9.722M |
| October 30, 2024 | 10.08M |
| October 29, 2024 | 9.868M |
| October 28, 2024 | 10.33M |
| October 25, 2024 | 9.736M |
| October 24, 2024 | 10.07M |
| October 23, 2024 | 8.219M |
| October 22, 2024 | 8.095M |
| October 21, 2024 | 7.846M |
| October 18, 2024 | 7.946M |
| October 17, 2024 | 7.930M |
| October 16, 2024 | 8.074M |
| October 15, 2024 | 8.432M |
| October 14, 2024 | 7.351M |
| October 11, 2024 | 7.002M |
| October 10, 2024 | 7.034M |
| Date | Value |
|---|---|
| October 09, 2024 | 7.813M |
| October 08, 2024 | 8.232M |
| October 07, 2024 | 7.977M |
| October 04, 2024 | 8.840M |
| October 03, 2024 | 9.058M |
| October 02, 2024 | 8.655M |
| October 01, 2024 | 9.089M |
| September 30, 2024 | 9.628M |
| September 27, 2024 | 9.676M |
| September 26, 2024 | 9.337M |
| September 25, 2024 | 9.433M |
| September 24, 2024 | 9.476M |
| September 23, 2024 | 9.802M |
| September 20, 2024 | 9.781M |
| September 19, 2024 | 9.352M |
| September 18, 2024 | 9.337M |
| September 17, 2024 | 9.432M |
| September 16, 2024 | 9.536M |
| September 13, 2024 | 9.761M |
| September 12, 2024 | 9.712M |
| September 11, 2024 | 9.672M |
| September 10, 2024 | 9.454M |
| September 09, 2024 | 9.199M |
| September 06, 2024 | 9.325M |
| September 05, 2024 | 9.225M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.806M
Minimum
Oct 06 2023
158.85M
Maximum
Nov 01 2021
53.05M
Average
54.16M
Median
Jun 09 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.013M |
| Revenue (Quarterly) | 0.1171M |
| Total Expenses (Quarterly) | 1.094M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 99.84% |
| Profit Margin (Quarterly) | -864.5% |
| Earnings Yield | -321.0% |
| Normalized Earnings Yield | -317.51 |